Page 3 - Mark Litton News Today

Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update On track to report topline data from ACT-AD Phase 2 Alzheimers disease study in 2Q22 ... | March 24, 2022

The chief executive Athira Pharma left the company after papers she published as a student were found to contain altered research.

Leen Kawas has formally resigned as CEO and president of Athira Pharma and is stepping off the board after an investigation found the biotech executive altered…

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Athira Pharma climbs on Alzheimer study news, while the CEO steps down over altered images in her research papers and dissertation.

Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer.

Athira Pharma, a Bothell-based biopharmaceutical company, announced Thursday that CEO and co-founder Leen Kawas has resigned from the company after an internal investigation found that she had altered images in her doctoral dissertation and “at least four research papers” written while she was at Washington State University.

Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review "stemming from doctoral research…

GuidesArch CityHome & StyleDiningFeaturesWeddingsLegals Columbus Alt-Rock Radio Station Survives Another Move Down the Dial How Randy Malloy and his band of alternative radio loyalists refused to let a beloved Columbus station die Chris DeVille The darkness settles around Randy Malloy, as if mirroring the story he’s unfurling. The owner and president of WWCD—the FM radio station formerly known as CD101 and CD102.5, recently reborn as CD92.9—is spending his 57th birthday retelling his most...